- $228.08m
- -$61.04m
- $137.42m
Annual income statement for Quanterix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K/A | 10-K/A | 10-K/A | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 86.4 | 111 | 106 | 122 | 137 |
| Cost of Revenue | |||||
| Gross Profit | 48.2 | 64.8 | 45.4 | 74.2 | 83.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 118 | 167 | 210 | 168 | 190 |
| Operating Profit | -31.6 | -56.5 | -104 | -46 | -52.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -31.9 | -55.6 | -99.4 | -27.6 | -38.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -31.5 | -55.5 | -99.6 | -28.4 | -38.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -31.5 | -55.5 | -99.6 | -28.4 | -38.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -31.5 | -55.5 | -99.6 | -28.4 | -38.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.07 | -1.54 | -2.17 | -0.731 | -1 |